Invention Grant
- Patent Title: Compositions and their uses directed to huntingtin
-
Application No.: US17352806Application Date: 2021-06-21
-
Publication No.: US11761000B2Publication Date: 2023-09-19
- Inventor: Susan M. Freier
- Applicant: IONIS PHARMACEUTICALS, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: IONIS PHARMACEUTICALS, INC.
- Current Assignee: IONIS PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Carlsbad
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- The original application number of the division: US11627916 2007.01.26
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113

Abstract:
Disclosed herein are compounds, compositions and methods for modulating the expression of huntingtin in a cell, tissue or animal. Further provided are methods of slowing or preventing Huntington's Disease (HD) progression using an antisense compound targeted to huntingtin. Additionally provided are methods of delaying or preventing the onset of Huntington's Disease (HD) in an individual susceptible to Huntington's Disease (HD). Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
Information query